COPZ1 and neoplasm: Immunohistochemical (IHC) staining performed on 60 paraffin-embedded clinical samples, including grade II (n = 18), grade III (n = 18), grade IV (n = 18) and non-neoplastic brain tissue samples (n = 6), confirmed the result that COPZ1 increased with increasing tumor grade.